Loading...

Matthew Kirkpatrick, PhD

Title(s)Assistant Professor of Research Preventive Medicine
AddressSSB 2001 N Soto St
Health Sciences Campus
Los Angeles CA 90033
Phone+1 323 442 8221
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Matt Kirkpatrick, PhD is an Assistant Professor of Research in the Department of Preventive Medicine in the Keck School of Medicine at the University of Southern California. He is associate director of the USC-Health, Emotion, & Addiction Laboratory (USC-HEAL), which conducts interdisciplinary research at the intersection between drug abuse, emotion, and health-related behaviors. He earned his B.A. in Religious Studies at the University of North Carolina at Chapel Hill and Ph.D. in Psychology at Columbia University. Dr. Kirkpatrick completed postdoctoral training in neuropsychopharmacology at the University of Chicago.

    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Social facilitation of alcohol subjective effects in adolescents: Associations with subsequent alcohol use. Psychopharmacology (Berl). 2021 Jan 06. Kirkpatrick MG, Cho J, Stone MD, Bae D, Barrington-Trimis JL, Pang RD, Leventhal AM. PMID: 33404735.
      View in: PubMed   Mentions:    Fields:    
    2. #FlavorsSaveLives: An analysis of Twitter posts opposing flavored e-cigarette bans. Nicotine Tob Res. 2021 Jan 04. Kirkpatrick MG, Dormanesh A, Rivera V, Majmundar A, Soto DW, Chen-Sankey JC, Cruz TB, Unger JB, Allem JP. PMID: 33394024.
      View in: PubMed   Mentions:    Fields:    
    3. E-cigarette product placement and imagery in popular music videos. Nicotine Tob Res. 2020 Dec 26. Escobedo P, Rosenthal EL, Saucier CJ, Unger JB, Cruz TB, Kirkpatrick M, Allem JP. PMID: 33367917.
      View in: PubMed   Mentions:    Fields:    
    4. Guidelines for Opioid Prescribing in Children and Adolescents After Surgery: An Expert Panel Opinion. JAMA Surg. 2020 Nov 11. Kelley-Quon LI, Kirkpatrick MG, Ricca RL, Baird R, Harbaugh CM, Brady A, Garrett P, Wills H, Argo J, Diefenbach KA, Henry MCW, Sola JE, Mahdi EM, Goldin AB, St Peter SD, Downard CD, Azarow KS, Shields T, Kim E. PMID: 33175130.
      View in: PubMed   Mentions:    Fields:    
    5. Content Analysis of Instagram Posts From 2019 With Cartoon-Based Marketing of e-Cigarette-Associated Products. JAMA Pediatr. 2020 Jul 20. Dormanesh A, Kirkpatrick MG, Allem JP. PMID: 32687566.
      View in: PubMed   Mentions:    Fields:    
    6. Developmental patterns of tobacco product and cannabis use initiation in high school. Addiction. 2020 Jun 13. Cho J, Goldenson NI, Kirkpatrick MG, Barrington-Trimis JL, Pang RD, Leventhal AM. PMID: 32533801.
      View in: PubMed   Mentions:    Fields:    
    7. Digital media use and subsequent cannabis and tobacco product use initiation among adolescents. Drug Alcohol Depend. 2020 07 01; 212:108017. Kelleghan AR, Leventhal AM, Cruz TB, Bello MS, Liu F, Unger JB, Riehm K, Cho J, Kirkpatrick MG, McConnell RS, Barrington-Trimis JL. PMID: 32408138.
      View in: PubMed   Mentions: 1     Fields:    
    8. E-cigarette device power moderates the effects of non-tobacco flavors and nicotine on product appeal in young adults. Addict Behav. 2020 08; 107:106403. Leventhal AM, Mason TB, Kirkpatrick MG, Anderson MK, Levine MD. PMID: 32222565.
      View in: PubMed   Mentions:    Fields:    
    9. Effectiveness of transdermal nicotine patch in premenopausal female smokers is moderated by within-subject severity of negative affect and physical symptoms. Psychopharmacology (Berl). 2020 Jun; 237(6):1737-1744. Chai SH, Leventhal AM, Kirkpatrick MG, Eisenlohr-Moul TA, Rapkin AJ, D'Orazio L, Pang RD. PMID: 32157328.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Detection of acute 3,4-methylenedioxymethamphetamine (MDMA) effects across protocols using automated natural language processing. Neuropsychopharmacology. 2020 04; 45(5):823-832. Agurto C, Cecchi GA, Norel R, Ostrand R, Kirkpatrick M, Baggott MJ, Wardle MC, Wit H, Bedi G. PMID: 31978933.
      View in: PubMed   Mentions: 2     Fields:    
    11. Sex differences in the appeal of flavored e-cigarettes among young adult e-cigarette users. Psychol Addict Behav. 2020 Mar; 34(2):303-307. Pang RD, Goldenson NI, Kirkpatrick M, Barrington-Trimis JL, Cho J, Leventhal AM. PMID: 31961168.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    12. Conceptualizing Health Behaviors as Acute Mood-Altering Agents: Implications for Cancer Control. Cancer Prev Res (Phila). 2020 04; 13(4):343-350. Dunton GF, Kaplan JT, Monterosso J, Pang RD, Mason TB, Kirkpatrick MG, Eckel SP, Leventhal AM. PMID: 31948998.
      View in: PubMed   Mentions:    Fields:    
    13. Sensory attributes of e-cigarette flavours and nicotine as mediators of interproduct differences in appeal among young adults. Tob Control. 2020 11; 29(6):679-686. Leventhal A, Cho J, Barrington-Trimis J, Pang R, Schiff S, Kirkpatrick M. PMID: 31852818.
      View in: PubMed   Mentions:    Fields:    
    14. Subjective effects of combustible, vaporized, and edible cannabis: Results from a survey of adolescent cannabis users. Drug Alcohol Depend. 2020 01 01; 206:107716. Ewusi Boisvert E, Bae D, Pang RD, Davis JP, Kelley-Quon LI, Barrington-Trimis JL, Kirkpatrick MG, Chai SH, Leventhal AM. PMID: 31718923.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    15. Flavored E-cigarette Use and Progression of Vaping in Adolescents. Pediatrics. 2019 11; 144(5). Leventhal AM, Goldenson NI, Cho J, Kirkpatrick MG, McConnell RS, Stone MD, Pang RD, Audrain-McGovern J, Barrington-Trimis JL. PMID: 31659004.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    16. Subjective effects from the first cigarette of the day vary with precigarette affect in premenopausal female daily smokers. Exp Clin Psychopharmacol. 2019 Aug 01. Pang RD, Guillot CR, Liautaud MM, Bello MS, Kirkpatrick MG, Huh J, Leventhal AM. PMID: 31368771.
      View in: PubMed   Mentions:    Fields:    
    17. Effects of non-tobacco flavors and nicotine on e-cigarette product appeal among young adult never, former, and current smokers. Drug Alcohol Depend. 2019 10 01; 203:99-106. Leventhal AM, Goldenson NI, Barrington-Trimis JL, Pang RD, Kirkpatrick MG. PMID: 31434028.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimals
    18. Cartoon-based e-cigarette marketing: Associations with susceptibility to use and perceived expectations of use. Drug Alcohol Depend. 2019 08 01; 201:109-114. Kirkpatrick MG, Cruz TB, Unger JB, Herrera J, Schiff S, Allem JP. PMID: 31207451.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    19. Characterising KandyPens-related posts to Instagram: implications for nicotine and cannabis use. Tob Control. 2020 07; 29(4):472-474. Majmundar A, Kirkpatrick M, Cruz TB, Unger JB, Allem JP. PMID: 31147484.
      View in: PubMed   Mentions: 7     Fields:    
    20. Indirect Associations of Anxiety Sensitivity with Tobacco, Alcohol, and Other Drug Use Problems Through Emotional Disorder Symptoms in Adolescents. Behav Med. 2020 Apr-Jun; 46(2):161-169. Guillot CR, Blackledge SM, Douglas ME, Cloutier RM, Liautaud MM, Pang RD, Kirkpatrick MG, Leventhal AM. PMID: 31039083.
      View in: PubMed   Mentions: 1     Fields:    
    21. Initial application of a human laboratory model for estimating the motivational substitutability of e-cigarettes for combustible cigarettes. Exp Clin Psychopharmacol. 2019 Apr; 27(2):125-135. Leventhal AM, Goldenson NI, Aguirre CG, Huh J, Kirkpatrick MG. PMID: 30688503.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    22. Strategies to find audience segments on Twitter for e-cigarette education campaigns. Addict Behav. 2019 04; 91:222-226. Chu KH, Allem JP, Unger JB, Cruz TB, Akbarpour M, Kirkpatrick MG. PMID: 30497815.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    23. Monitoring Tobacco Brand Websites to Understand Marketing Strategies Aimed at Tobacco Product Users and Potential Users. Nicotine Tob Res. 2018 09 25; 20(11):1393-1400. PMID: 29059386.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    24. Pain as a predictor and consequence of tobacco abstinence effects amongst African American smokers. J Abnorm Psychol. 2018 Oct; 127(7):683-694. Bello MS, McBeth JF, Ditre JW, Kirkpatrick MG, Ray LA, Dunn KE, Leventhal AM. PMID: 30070540.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    25. Return of cartoon to market e-cigarette-related products. Tob Control. 2019 09; 28(5):555-557. Allem JP, Cruz TB, Unger JB, Toruno R, Herrera J, Kirkpatrick MG. PMID: 30049688.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    26. Rewarding effects of physical activity predict sensitivity to the acute subjective effects of d-amphetamine in healthy volunteers. J Psychopharmacol. 2018 03; 32(3):302-308. Pester MS, Kirkpatrick MG, Geary BA, Leventhal AM. PMID: 29338486.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    27. Validation of a behavioral economic purchase task for assessing drug abuse liability. Addict Biol. 2019 03; 24(2):303-314. PMID: 29314376.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    28. Ovarian Hormones and Transdermal Nicotine Administration Independently and Synergistically Suppress Tobacco Withdrawal Symptoms and Smoking Reinstatement in the Human Laboratory. Neuropsychopharmacology. 2018 03; 43(4):828-837. PMID: 28905874.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    29. Anhedonia and Abstinence as Predictors of the Subjective Pleasantness of Positive, Negative, and Smoking-Related Pictures. Nicotine Tob Res. 2017 Jun 01; 19(6):743-749. PMID: 28186553.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    30. Impulsivity and history of behavioral addictions are associated with drug use in adolescents. Addict Behav. 2017 11; 74:41-47. Chuang CI, Sussman S, Stone MD, Pang RD, Chou CP, Leventhal AM, Kirkpatrick MG. PMID: 28570913.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    31. Electronic cigarette retailers use Pokémon Go to market products. Tob Control. 2017 12; 26(e2):e145-e147. PMID: 28044010.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    32. Pharmacogenetics of stimulant abuse liability: association of CDH13 variant with amphetamine response in a racially-heterogeneous sample of healthy young adults. Psychopharmacology (Berl). 2017 Jan; 234(2):307-315. PMID: 27771748.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    33. Effects of sweet flavorings and nicotine on the appeal and sensory properties of e-cigarettes among young adult vapers: Application of a novel methodology. Drug Alcohol Depend. 2016 Nov 01; 168:176-180. PMID: 27676583.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansAnimalsCTClinical Trials
    34. Urinary and plasma oxytocin changes in response to MDMA or intranasal oxytocin administration. Psychoneuroendocrinology. 2016 12; 74:92-100. PMID: 27592327.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    35. Transdiagnostic processes linking anxiety symptoms and substance use problems among adolescents. J Addict Dis. 2016 Oct-Dec; 35(4):266-277. PMID: 27431313.
      View in: PubMed   Mentions: 8     Fields:    
    36. Social Self-Control Is a Statistically Nonredundant Correlate of Adolescent Substance Use. Subst Use Misuse. 2016 05 11; 51(6):788-94. PMID: 27070833.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    37. Asians compared to Whites show increased response to d-amphetamine on select subjective and cardiovascular measures. Pharmacol Biochem Behav. 2016 May; 144:73-7. PMID: 26952590.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    38. Oxytocin receptor gene variation predicts subjective responses to MDMA. Soc Neurosci. 2016 12; 11(6):592-9. PMID: 26787430.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    39. Premenstrual symptoms and smoking-related expectancies. Addict Behav. 2016 Jun; 57:38-41. PMID: 26869196.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    40. Social contexts of momentary craving to smoke among Korean American emerging adults. Addict Behav. 2016 May; 56:23-9. PMID: 26802789.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    41. Psychiatric comorbidity in adolescent electronic and conventional cigarette use. J Psychiatr Res. 2016 Feb; 73:71-8. PMID: 26688438.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    42. Emotional traits predict individual differences in amphetamine-induced positive mood in healthy volunteers. Psychopharmacology (Berl). 2016 Jan; 233(1):89-97. PMID: 26429791.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    43. Meta-analysis of Genome-Wide Association Studies for Extraversion: Findings from the Genetics of Personality Consortium. Behav Genet. 2016 Mar; 46(2):170-82. PMID: 26362575.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    44. Initial Validation of the Pleasure and Health Behavior Inventory - A Measure of Motivation to Engage in Health-damaging Behavior to Overcome Deficient Pleasure. Am J Health Behav. 2015 Sep; 39(5):652-64. PMID: 26248175.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    45. Association of Electronic Cigarette Use With Initiation of Combustible Tobacco Product Smoking in Early Adolescence. JAMA. 2015 Aug 18; 314(7):700-7. PMID: 26284721.
      View in: PubMed   Mentions: 278     Fields:    Translation:Humans
    46. Meta-analysis of Genome-wide Association Studies for Neuroticism, and the Polygenic Association With Major Depressive Disorder. JAMA Psychiatry. 2015 Jul; 72(7):642-50. PMID: 25993607.
      View in: PubMed   Mentions: 68     Fields:    Translation:Humans
    47. Diminished Alternative Reinforcement as a Mechanism Underlying Socioeconomic Disparities in Adolescent Substance Use. Prev Med. 2015 Nov; 80:75-81. PMID: 26051200.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    48. Effects of acute doses of prosocial drugs methamphetamine and alcohol on plasma oxytocin levels. J Clin Psychopharmacol. 2015 Jun; 35(3):308-12. PMID: 25853370.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    49. Pharmacological, sensorimotor, and expectancy effects on tobacco withdrawal: a preliminary study. Hum Psychopharmacol. 2015 Sep; 30(5):364-71. PMID: 26010521.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    50. Intimate insight: MDMA changes how people talk about significant others. J Psychopharmacol. 2015 Jun; 29(6):669-77. PMID: 25922420.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    51. Prosocial effects of MDMA: A measure of generosity. J Psychopharmacol. 2015 Jun; 29(6):661-8. PMID: 25735993.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    52. Examination of anxiety sensitivity and distress tolerance as transdiagnostic mechanisms linking multiple anxiety pathologies to alcohol use problems in adolescents. Alcohol Clin Exp Res. 2015 Mar; 39(3):532-9. PMID: 25706521.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    53. MDMA: a social drug in a social context. Psychopharmacology (Berl). 2015 Mar; 232(6):1155-63. PMID: 25281223.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    54. Plasma oxytocin concentrations following MDMA or intranasal oxytocin in humans. Psychoneuroendocrinology. 2014 Aug; 46:23-31. PMID: 24882155.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    55. 'Ecstasy' as a social drug: MDMA preferentially affects responses to emotional stimuli with social content. Soc Cogn Affect Neurosci. 2014 Aug; 9(8):1076-81. PMID: 24682132.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    56. MDMA effects consistent across laboratories. Psychopharmacology (Berl). 2014 Oct; 231(19):3899-905. PMID: 24633447.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    57. Effects of MDMA and Intranasal oxytocin on social and emotional processing. Neuropsychopharmacology. 2014 Jun; 39(7):1654-63. PMID: 24448644.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    58. In the company of others: social factors alter acute alcohol effects. Psychopharmacology (Berl). 2013 Nov; 230(2):215-26. PMID: 23712603.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    59. Intranasal substituted cathinone "bath salts" psychosis potentially exacerbated by diphenhydramine. J Addict Med. 2013 May-Jun; 7(3):163-8. PMID: 23732955.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    60. Personality and the acute subjective effects of d-amphetamine in humans. J Psychopharmacol. 2013 Mar; 27(3):256-64. PMID: 23343596.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    61. Comparison of intranasal methamphetamine and d-amphetamine self-administration by humans. Addiction. 2012 Apr; 107(4):783-91. PMID: 22050030.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    62. Acute and residual interactive effects of repeated administrations of oral methamphetamine and alcohol in humans. Psychopharmacology (Berl). 2012 Jan; 219(1):191-204. Kirkpatrick MG, Gunderson EW, Levin FR, Foltin RW, Hart CL. PMID: 21748253.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    63. A direct comparison of the behavioral and physiological effects of methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology (Berl). 2012 Jan; 219(1):109-22. PMID: 21713605.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    64. Zolpidem does not serve as reinforcer in humans subjected to simulated shift work. Drug Alcohol Depend. 2010 Nov 01; 112(1-2):168-71. Kirkpatrick MG, Haney M, Vosburg SK, Comer SD, Foltin RW, Hart CL. PMID: 20655669.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    65. Methamphetamine self-administration by humans subjected to abrupt shift and sleep schedule changes. Psychopharmacology (Berl). 2009 May; 203(4):771-80. Kirkpatrick MG, Haney M, Vosburg SK, Comer SD, Foltin RW, Hart CL. PMID: 19052727.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    66. Residual effects of intranasal methamphetamine on sleep, mood, and performance. Drug Alcohol Depend. 2008 Apr 01; 94(1-3):258-62. Perez AY, Kirkpatrick MG, Gunderson EW, Marrone G, Silver R, Foltin RW, Hart CL. PMID: 18078723.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    67. Effects of intranasal methamphetamine on metacognition of agency. Psychopharmacology (Berl). 2008 Mar; 197(1):137-44. Kirkpatrick MG, Metcalfe J, Greene MJ, Hart CL. PMID: 18043908.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    68. Acute physiological and behavioral effects of intranasal methamphetamine in humans. Neuropsychopharmacology. 2008 Jul; 33(8):1847-55. Hart CL, Gunderson EW, Perez A, Kirkpatrick MG, Thurmond A, Comer SD, Foltin RW. PMID: 17851535.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    Matthew's Networks
    Concepts (210)
    Derived automatically from this person's publications.
    _
    Co-Authors (18)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _